Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab.
Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, Curiale GG, Tian Y, Patel D, von Rosenstiel P, von Hehn C, Salloway S, Hock C, Nitsch RM, Haeberlein SB, Sandrock A, Singhal P.
Chen T, et al. Among authors: o gorman j.
Alzheimers Dement. 2024 Apr 3. doi: 10.1002/alz.13755. Online ahead of print.
Alzheimers Dement. 2024.
PMID: 38567735